ABT: Abbott Laboratories Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 179,230.75
Enterprise Value ($M) 194,623.07
Book Value ($M) 30,925.00
Book Value / Share 17.53
Price / Book 5.77
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) 0.05
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.08

Liquidity (mrq)
Quick Ratio 1.13
Current Ratio 1.58

Balance Sheet (mrq) ($M)
Current Assets 14,409.00
Assets 67,610.00
Liabilities 36,685.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income 3,650.00
Net Income 2,368.00
Earnings Per Share Diluted 1.33
Earnings Per Share Basic 1.34

Cash Flow Statement (mra) ($M)
Cash From Operations 6,300.00
Cash from Investing -1,356.00
Cash from Financing -1,356.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-14 13G/A Capital Research Global Investors 6.40 -6.76
2020-02-12 13G/A Vanguard Group Inc 8.58 5.21
2020-02-05 13G/A BlackRock Inc. 7.10 3.04

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2020-07-29 10-Q Quarterly Report – 10-Q
2020-04-29 10-Q Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2020;
2020-02-21 10-K Abbott Laboratories' Annual Report (Form 10-K) for the year ended December 31, 2019
2019-10-31 10-Q ABT / Abbott Laboratories 10-Q – Quarterly Report – 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-08-07 262,891 3,141,900 8.37
2020-08-06 468,163 3,942,900 11.87
2020-08-05 634,483 4,416,000 14.37
2020-08-04 375,173 2,730,500 13.74

(click for more detail)

(click for list of largest short owners)

Similar Companies
ABBV – AbbVie Inc. AGN – Allergan plc
ALR – Alere Inc.


Financial data and stock pages provided by
Fintel.io